Epoxide hydrolase

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 26: Line 26:
**[[1qo7]], [[3g02]] – AnEH (mutant) – ''Aspergillus niger''<br />
**[[1qo7]], [[3g02]] – AnEH (mutant) – ''Aspergillus niger''<br />
**[[2cjp]] – pEH I – potato<br />
**[[2cjp]] – pEH I – potato<br />
-
**[[3cxu]] – pEH (mutant) <br />
+
**[[3cxu]], [[4ufn]], [[4ufo]], [[4ufp]], [[4uhb]], [[4y9s]] – pEH (mutant) <br />
-
**[[4i19]], [[4qa9]] – EH – ''Streptomyces carzinostaticus''<br />
+
**[[4i19]], [[4qa9]], [[4f4z]] – EH – ''Streptomyces carzinostaticus''<br />
*Soluble epoxide hydrolase
*Soluble epoxide hydrolase
-
**[[1s8o]], [[3i1y]], [[3i28]], [[3koo]], [[5ahx]] – hSEH – human<br />
+
**[[1s8o]], [[3i1y]], [[3i28]], [[3koo]], [[5ahx]], [[5fp0]] – hSEH – human<br />
**[[1cqz]] – mSEH – mouse<br />
**[[1cqz]] – mSEH – mouse<br />
**[[4nzz]] – BmSEH – ''Bacillus megaterium''<br />
**[[4nzz]] – BmSEH – ''Bacillus megaterium''<br />
Line 82: Line 82:
**[[1nww]] – ReEH – ''Rhodococcus erythropolis''<br />
**[[1nww]] – ReEH – ''Rhodococcus erythropolis''<br />
-
**[[4r9k]], [[4r9l]], [[4xbx]], [[4xdw]] – ReEH (mutant)<br />
+
**[[4r9k]], [[4r9l]], [[4xbx]], [[4xdw]], [[5cf1]], [[5cf2]], [[5jpp]] – ReEH (mutant)<br />
**[[1nu3]] – ReEH + valpromide <br />
**[[1nu3]] – ReEH + valpromide <br />
-
**[[4xbt]], [[4xdv]] – ReEH (mutant) + cyclohexanediol<br />
+
**[[4xbt]], [[4xdv]], [[5clk]], [[5jpu]] – ReEH (mutant) + cyclohexanediol<br />
-
**[[4xby]] – ReEH (mutant) + cyclopentene oxi
+
**[[4xby]], [[5ck6]] – ReEH (mutant) + cyclopentene oxide<br />
 +
**[[5aif]], [[5aih]], [[5aii]] – mlEH – metagenomic library<br />
 +
**[[5aig]] – mlEH + valpromide <br />
 +
 
}}
}}
== References ==
== References ==
<references/>
<references/>

Revision as of 10:39, 3 May 2017

Human soluble epoxide hydrolase complex with imidazole derivative inhibitor (PDB code 5alf)

Drag the structure with the mouse to rotate

3D Structures of epoxide hydrolase

Updated on 03-May-2017

References

  1. Biswal BK, Morisseau C, Garen G, Cherney MM, Garen C, Niu C, Hammock BD, James MN. The molecular structure of epoxide hydrolase B from Mycobacterium tuberculosis and its complex with a urea-based inhibitor. J Mol Biol. 2008 Sep 12;381(4):897-912. Epub 2008 Jun 17. PMID:18585390 doi:10.1016/j.jmb.2008.06.030
  2. Arand M, Hallberg BM, Zou J, Bergfors T, Oesch F, van der Werf MJ, de Bont JA, Jones TA, Mowbray SL. Structure of Rhodococcus erythropolis limonene-1,2-epoxide hydrolase reveals a novel active site. EMBO J. 2003 Jun 2;22(11):2583-92. PMID:12773375 doi:http://dx.doi.org/10.1093/emboj/cdg275
  3. Imig JD, Hammock BD. Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases. Nat Rev Drug Discov. 2009 Oct;8(10):794-805. doi: 10.1038/nrd2875. PMID:19794443 doi:http://dx.doi.org/10.1038/nrd2875
  4. Oster L, Tapani S, Xue Y, Kack H. Successful generation of structural information for fragment-based drug discovery. Drug Discov Today. 2015 Apr 28. pii: S1359-6446(15)00154-3. doi:, 10.1016/j.drudis.2015.04.005. PMID:25931264 doi:http://dx.doi.org/10.1016/j.drudis.2015.04.005

Proteopedia Page Contributors and Editors (what is this?)

Michal Harel, Alexander Berchansky, Joel L. Sussman

Personal tools